Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire. (September 2013)
- Record Type:
- Journal Article
- Title:
- Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire. (September 2013)
- Main Title:
- Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire
- Authors:
- Watzlawik, Jens O
Wootla, Bharath
Painter, Meghan M
Warrington, Arthur E
Rodriguez, Moses - Abstract:
- Immunoglobulins with germline sequences occur in invertebrates and vertebrates and are named naturally occurring autoantibodies (NAbs). NAbs may target foreign antigens, self- or altered self-components and are part of the normal immunoglobulin repertoire. Accumulating evidence indicates that naturally occurring antibodies can act as systemic surveillance molecules, which tag, damaged or stressed cells, invading pathogens and toxic cellular debris for elimination by the immune system. In addition to acting as detecting molecules, certain types of NAbs actively signal in different cell types with a broad range of responses from induction of apoptosis in cancer cells to stimulation of remyelination in glial cells. This review emphasizes functions and characteristics of NAbs with focus on remyelination-promoting mouse and human antibodies. Human remyelination-promoting NAbs are potential therapeutics to combat a wide spectrum of disease processes including demyelinating diseases like multiple sclerosis. We will highlight the identified glycosphingolipid (SL) antigens of polyreactive remyelination-promoting antibodies and their proposed mechanism(s) of action. The nature of the identified antigens suggests a lipid raft-based mechanism for remyelination-promoting antibodies with SLs as most essential raft components. However, accumulating evidence also suggests involvement of other antigens in stimulation of remyelination, which will be discussed in the text.
- Is Part Of:
- Expert review of neurotherapeutics. Volume 13:Number 9(2013)
- Journal:
- Expert review of neurotherapeutics
- Issue:
- Volume 13:Number 9(2013)
- Issue Display:
- Volume 13, Issue 9 (2013)
- Year:
- 2013
- Volume:
- 13
- Issue:
- 9
- Issue Sort Value:
- 2013-0013-0009-0000
- Page Start:
- 1017
- Page End:
- 1029
- Publication Date:
- 2013-09
- Subjects:
- autoantibodies -- apoptosis -- demyelination -- multiple sclerosis -- proliferation -- TMEV animal model
Neuropharmacology -- Periodicals
615.7805 - Journal URLs:
- http://www.expert-reviews.com/loi/ern ↗
http://www.future-drugs.com/loi/ern ↗
http://www.tandfonline.com/toc/iern20/current ↗
http://informahealthcare.com ↗ - DOI:
- 10.1586/14737175.2013.835601 ↗
- Languages:
- English
- ISSNs:
- 1473-7175
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002995
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 16226.xml